ViewsML
Founded in 2026, ViewsML is led by CEO Kenneth To. The company is developing the world first virtual biomarker library, which utilizes artificial intelligence to extract per-cell spatial biomarker insights from routine pathology images, effectively transforming a traditionally laboratory-bound diagnostic process into a software-based workflow.
Funding
Every round, secondary, debt facility or acquisition involving ViewsML that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $19/mo.
See plans →Log in